Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Radiotherapy indications in non-Hodgkin lymphoma].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique - 1 Oct 2009

Quero L, Hennequin C, Brice P

Abstract excerpt

Actually, radiation-therapy indications in non-Hodgkin's lymphoma tends to decrease in favour of exclusive chemotherapy, especially in aggressive localized diseases. In this situation, PET scan imaging would be a promising tool to identify candidates to complementary radiotherapy after initial chemotherapy. To decrease long-term morbidity, radiation doses and treated volumes should be as small as possible. New...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclophosphamide

Share to Doxorubicin

Share to Lymphoma, Non-Hodgkin

Share to Prednisone

Share to Radiotherapy Dosage

Share to Vincristine

Source

Identifiers

PMID: 19695926
DOI: 10.1016/j.canrad.2009.07.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

[Radiotherapy indications in non-Hodgkin lymphoma].PMID 19695926Read ↗

Metabolic Imaging in B-Cell Lymphomas during CAR-T Cell TherapySemantic proximity Read ↗

Exploration of Optimal Reconstruction Parameters for 18F-FDG Total-body PET/CT with Ultra-low Activity InjectionSemantic proximity Read ↗

(89) Zr-rituximab PET/CT to detect neurolymphomatosis.Semantic proximity Read ↗

Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.Semantic proximity Read ↗

Impact of four-dimensional cone-beam computed tomography on target localization for gastric mucosa-associated lymphoid tissue lymphoma radiotherapy: reducing planning target volumeSemantic proximity Read ↗

Determining the Optimal Dose of 18F-FDG for Hodgkin lymphoma Imaging on PET/CT Camera with BGO CrystalsSemantic proximity Read ↗

Optimizing acquisition times for total-body positron-emission tomography/computed tomography with half-dose 18F-fluorodeoxyglucose in oncology patientsSemantic proximity Read ↗

Radiotherapy for primary localized (stage I and II) non-Hodgkin's lymphoma of the oral cavity.Semantic proximity Read ↗

Clinical implementation of PLANET®Dose for dosimetric assessment after [177Lu]Lu-DOTA-TATE: comparison with Dosimetry Toolkit® and OLINDA/EXM® V1.0Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.